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Abstract
The bovine spongiform encephalopathy (BSE) epidemic in 1986 highlighted the
importance of the rendering industry as a key component of the food supply chain.
Prior to 1986 the rendering industry was poorly understood. However, following the
emergence of BSE research was commissioned to characterise rendering systems
and investigate their ability to inactivate transmissible spongiform encephalopathy
(TSE) agents. Six rendering systems were found to be operational in Europe but their
key process parameters, such as particle size, process temperature and transit time,
were poorly characterised. This review describes how these key process parameters
were determined and used to inform protocols for the subsequent TSE inactivation
trials which subsequently shaped both EU legislation and the development of tech-
niques used to validate rendering systems. It also describes how EU legislation ban-
ning the use of animal-derived proteins in animal feeds ('feed ban') effectively
eliminated the market for meat and bone meal (MBM) and how the rendering indus-
try sought to 'add value' to rendered products by conducting research to support the
development of new markets for rendered products. The nutritional, environmental
and economic characteristics of modern processed animal proteins (PAPs) mean that
they represent valuable ingredients for use in animal feeds. Recent research has
paved the way for legislative changes allowing the safe reintroduction of non-
ruminant PAP into aqua-feeds and may soon facilitate their reintroduction into pig
and poultry feeds. However, resistance from key stakeholders in the food chain
remains a significant challenge that must be overcome before their full potential can
be realised. Further research is required to characterise modern PAPS and to ensure
their appropriate, safe and acceptable inclusion in animal feeds.
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1 | INTRODUCTION
Following the bovine spongiform encephalopathy (BSE) epidemic in
1986 the use of meat and bone meal (MBM) was banned in the diet
of animals kept for food production (EC No. 999/2001) (Regulation
(EC), 2001). However, with increasing demand for animal products,
and sustainable intensification of production systems, the nutritional,
environmental and economic characteristics of modern processed ani-
mal proteins (PAP) mean that they represent valuable ingredients and
the EU is currently considering relaxing the legislation to allow their
reintroduction into animal feeds. BSE was arguably one of the most
significant animal diseases in the 20th century, with over 180,000 cat-
tle being infected, 4.4 million slaughtered up to the end of 2000 and
an estimated cost of £5 billion (Brown et al., 2001). The emergence of
BSE in 1986 and its subsequent evolution as an epidemic brought ani-
mal by-products (ABP) and the rendering industry to the attention of
the public for the first time and emphasised their importance in the
food supply chain. Before this time, the rendering industry was poorly
understood, and it was generally assumed that the BSE epidemic was
caused that a relaxation in rendering standards. This review will evalu-
ate the role of the rendering industry in the BSE epidemic, the devel-
opment of current EU legislation concerning ABP and the recent
debate about the reintroduction of PAPs into animal feeds. It will also
describe how the rendering industry has evolved in response to the
BSE epidemic such that it can continue to operate and provide both a
valuable service and products to the livestock and meat industries.
2 | THE RENDERING INDUSTRY AND BSE
2.1 | Rendering
Rendering is the process of separating (rendering apart) the fat and
protein-rich material contained in animal tissues when they are heated
to a temperature where the cellular structure is degraded and the fats
are released (Woodgate & Van der Veen, 2004). Thereafter, the liquid
fat is separated from the protein-rich solid fraction. Although the defi-
nition of 'rendering' could equally be applied to the cooking of meat, it
is uniquely applied to the heat processing of ABP. In Europe, ABP are
defined as whole animals (e.g., fallen stock) or parts of animals raised
for human food production that humans choose not to eat
(Regulation [EC] No. 1774/2002) (Regulation (EC), 2002b). The key
stages in the rendering process are presented in Figure 1. Rendering
produces two main products: (1) rendered fat (RF, liquid at >50C)
and (2) a protein-rich solid material termed either MBM (pre-2002) or
MBM from Category 1 and 2 material and PAP from Category 3 mate-
rial (PAP, post-2002). Prior to BSE the RF (tallow) was traditionally
used in the manufacture of candles and soaps and was used in the
oleo-chemical industry, whereas the protein meal was used as a pro-
tein supplement in animal feeds. The rendering industry essentially
provides a service to the livestock and meat industries, but in com-
mercial terms, the revenue from selling rendered products must cover
the costs associated with ABP processing. Profit margins are
effectively maintained by either paying for, or charging for ABP,
depending on the value of the rendered products produced. Early
development of the rendering industry has been described by Bur-
nham (1978) and for many years it was termed the 'invisible industry'
because it operated outside the glare of publicity and legislative con-
trols were limited. If the MBM was 'cooked' (i.e., dry to the feel of the
operator) the process was thought to be working well. The legislative
controls that did exist centred on the control of Salmonella in MBM
as specified in the Disease of Animals (Protein Processing) Order
1981 (Order, 1981).
Between 1970 and 1980 significant changes occurred in the ren-
dering industry. The oil crisis in the mid-1970s resulted in a fivefold
increase in the cost of crude oil. With increasing fuel costs the render-
ing industry became acutely aware of the costs associated with pro-
ducing process heat (steam) and were forced to consider more energy
efficient processes to evaporate the same amount of water using sig-
nificantly less energy (Kudra & Mujumdar, 2001). Significant invest-
ment occurred in a new rendering system designed and built in the
United States. Termed the 'Anderson Carver-Greenfield' system, it
was designed to minimise fuel use and reduce processing costs. The
system was purchased by the main UK rendering company and three
plants were quickly established in the UK. By 1982 these plants were
processing approximately 30% of UK ABP. The key features of the
new system were the incorporation of a two-stage vacuum
F IGURE 1 Schematic diagram of the rendering process
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evaporation step, with high throughput and reduced temperature
because of the vacuum reducing the boiling point of the water. The
system used 0.8 kg steam kg−1 water evaporated compared to the
next most common system which required 1.35 kg steam kg−1 water
evaporated (Berge, 1986), with a resultant reduction in processing
costs of approximately 40%. However, the internal process dynamics
of the system remained poorly understood, although the fact that the
process temperature was lower than other systems was thought to
increase the digestibility and economic value of the MBM as an animal
feed (Wang & Parsons, 1998). The process was approved by the Min-
istry of Agriculture, Fisheries and Food (MAFF) to operate in accor-
dance with the Disease of Animals (Protein Processing) Order 1981
(Order, 1981) and raised no concerns.
2.2 | Meat and bone meal
In the early 1980s the market for rendered products (MBM and
RF) was relatively mature. MBM had only one application as an
ingredient in animal feeds, where it was widely used in the diets of
most farm animals. Its key attribute was its high-protein content
and relatively good amino acid balance (Table 1), particularly for
pigs and poultry (Crawshaw, 1995). For ruminants, the protein had
a low rumen degradability which was important to increase
undegradable protein supply (UDP) and satisfy the requirement of
high-producing animals. In the UK, the use of high UDP feedstuffs
was particularly relevant as dairy farmers were trying to increase
milk yields prior to the imposition of milk quotas. In the mid-
1980s, MBM was included in ruminant rations at up to 70 g kg−1
DM (BSE Inquiry, 2000).
2.3 | Emergence of BSE
In November 1986, BSE was identified in the UK cattle herd for the
first time (Wells et al., 1987). BSE is a fatal disease predominately of
cattle over 5 years of age that belongs to a group of diseases termed
transmissible spongiform encephalopathies (TSEs) that include scrapie
in sheep and goats and Creutzfeldt–Jakob disease (CJD) in humans.
The disease is caused by the mutation of a protein complex called a
prion, producing an accumulation of insoluble glycoproteins and
lesions in the brain of infected animals. Disease progression is slow,
with the incubation period being up to 5 years and oral ingestion
being the most infectious method of natural transmission. Lesions
TABLE 1 Chemical composition of meat and bone meal (MBM, pre-2002), and processed animal proteins (PAPs, post-2002)
Chemical composition (g kg−1 DM)
Pre-2002 Post-2002
MBMa,b Poultry PAPc Porcine PAPd Porcine PAPd
DM (g kg−1) 935 947 970 964–978
Crude protein 529 564 547 416–616
Ether extract 175 107 107 96–118
Ash 250 256 302 183–437
Calcium 57 103 52–160
Phosphorus 28 52 30–77
Amino acids (g kg−1 DM)
Threonine 15.9 22.4 16.9 11.4–20.7
Cysteine 6.2 5.6 3.3 1.5–5.3
Valine 20.1 24.9





Lysine 25.7 37.2 28.1 19.7–32.5
Histidine 8.9 14.7
Arginine 36.2 40.7
Rumen degradabilitye (outflow rate 0.08) 0.41 Not determined
aMinistry of Agriculture Fisheries and Food (MAFF) (1986).
bWang & Parsons (1998).
cLiland et al. (2015).
dVan Krimpen et al. (2010).
eAgricultural Research Council (ARC) (1984).
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within the brain progressively affect the host animal's behaviour and
mental state causing changes in gait and posture. As the senses
become hypersensitive, the host becomes nervous, aggressive and
frequently presses their head against objects, eventually leading to
recumbency, coma and death (Kimberlin, 1993). At the time little was
known about TSE inactivation. However, it was thought that the BSE
agent was likely to be difficult to destroy by atmospheric heating
alone and that only hyperbaric pressure would be effective
(Taylor, 1990).
3 | CHARACTERISATION OF RENDERING
PROCESSES
3.1 | Preliminary investigations
Immediately following the emergence of BSE, MAFF commissioned an
epidemiological study which concluded that a feed borne vector was
implicated in the aetiology of the disease (Wilesmith et al., 1988). A
subsequent survey of the animal feed industry then confirmed that
MBM was the only common feed factor that could explain the epi-
demic at this stage (BSE Inquiry, 2000). Thereafter, the spotlight was
clearly focussed on MBM and the rendering industry. Unfortunately,
owing to its unstructured nature very little information was available.
In response, MAFF commissioned a survey of the rendering industry,
the objectives of which were to characterise rendering systems, par-
ticularly the time and extent of heat treatment during the rendering
process (BSE Inquiry, 2000). The results highlighted that there were a
wide range of systems in operation but that their internal process
dynamics were poorly understood.
In order to better characterise rendering processes, MAFF con-
vened a working group consisting of MAFF, the Institute of Animal
Health Neuropathogenesis Unit (NPU), Edinburgh and representatives
of the rendering industry in May 1990. The terms of reference of this
working group were to formulate a joint research programme to investi-
gate the ability of rendering systems to inactivate TSE agents (BSE
Inquiry, 2000). This was quickly subsumed by the Scientific Veterinary
Committee of the European Union (SVC), which advised the European
Commission on protecting animal health and through that human health
in all member states (R. Bradley, 2017, personal communication). The
priority of the SVC TSE Working Group was to survey both the United
Kingdom Renderers Association (UKRA) and the European Renderers
Association (EURA) to characterise rendering systems. The survey
results revealed that rendering systems could be characterised by
(1) system (batch or continuous), (2) ABP treatment (as-received, added-
fat, fat-removed) and (3) pressure treatment (atmospheric, vacuum or
hyperbaric). In total, there were 18 potential combinations. However,
within Europe only six were operational (Table 2). These consisted of
two batch systems and four continuous systems as follows.
3.2 | Rendering systems
3.2.1 | Batch/as-received/atmospheric
This traditional system involved mincing the ABP to approximately 50 mm.
The minced ABP was then loaded into a batch cooker with a capacity of
1–10 t via a top hatch/vent. A central paddle then mixed the ABP with
heat being applied indirectly via the jacket of the cooker as high-pressure
steam. Water was removed as steam through the top vent until the ABP
was dry. Subsequently, the processed material was discharged into a
trough, prior to pressing and cooling to produce MBM, and a RF product.
3.2.2 | Batch/as-received/hyperbaric
This traditional system was similar to the batch/as-received/atmo-
spheric system described above. However, steam pressure was
applied by closing the top hatch/vent after air in the cooker was dis-
placed. The cooker pressure (typically 5–6 bars) was controlled by
adjusting the steam pressure in the cooker jacket for a defined period.
Following this period, the top hatch/vent was opened to allow the
water to evaporate as steam until the ABP was dry.
3.2.3 | Continuous/added-fat/vacuum
As stated previously, the 'Anderson Carver-Greenfield system'
(Figure 2) was a relatively new system, which by 1985 was used to pro-
cess approximately 30% of all UK ABP. The process involved mincing
TABLE 2 Characterisation of
rendering systems used in the European
Union prior to the bovine spongiform
encephalopathy (BSE) epidemic in 1986
Rendering systema
Key process parameters
System ABP treatment Pressure treatment
Batch atmospheric Batch As received Atmospheric
Batch hyperbaric Batch As received Hyperbaric
Anderson Carver-Greenfield Continuous Added fat Vacuum
Stord-Bartz Continuous As received Atmospheric
Equocooker Continuous Added fat Atmospheric
Wet rendering Continuous Fat removed Atmospheric
Abbreviation: ABP, animal by-products.
aThe rendering industry characterised rendering system by their trade names.
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the ABP to reduce the particle size to <10 mm. The minced ABP was
then mixed with RF in a 1:5 ratio. The RF acted as a carrier for the ABP
and medium to maximise the rate of evaporation. The two-stage falling
film evaporators facilitated evaporation of water at lower temperatures
(first stage 120C; second stage 105C) than would occur at normal
atmospheric pressure. Subsequently, the RF was then separated by cen-
trifugation with the solid material being pressed and cooled and milled
to produce MBM. The rendered fat was then recycled with the system
with the excess being filtered to produce a RF product.
3.2.4 | Continuous/as-received/atmospheric
The 'Stord Bartz system' involved mincing the ABP to <30 mm. The
minced ABP was then introduced into a continuous disc type drier
with the material being moved through the drier by a series of rotating
paddles. At discharge, the material was pressed, cooled and milled to
produce MBM and RF.
3.2.5 | Continuous/added-fat/atmospheric
The 'Equocooker system' involved mincing the ABP to <30 mm. The
minced ABP was then introduced into a cylindrical vessel containing
RF heated to 100–125C (0.60 volume), with the material being
moved through the process by a series of rotating paddles. At dis-
charge, the solid material was separated by filtration, cooled and
milled to produce MBM. The RF was then recycled within the system,
with the excess being filtered to produce an RF product.
3.2.6 | Continuous/fat-removed/atmospheric
The 'low-temperature rendering system' involved mincing the ABP to
<20 mm. The minced ABP was then pumped into a vessel (coagulator),
which heated the material to 95C. The heated material was then
pressed, dried in a continuous disc drier, cooled and milled to produce
MBM. The liquid fraction, containing RF and water was then cen-
trifuged to separate out the RF product.
3.3 | Process dynamics
In addition to characterising rendering systems, the survey
highlighted the key process parameters that could potentially affect
the ability of rendering systems to inactivate TSE agents. These
were ABP particle size, fat treatment, process temperature and tran-
sit time. The ABP particle size influenced the surface area of material
subject to processing conditions and the degree of heat penetration.
Within rendering systems, particle size reduction (mincing) was con-
trolled by altering the gap between the mincer anvils (anvil gap).
Considerable variation in particle size was found to exist both within
and between systems. In order to account for this, the SVC TSE
Working Group agreed to assign a typical particle size to each ren-
dering system. The addition or removal of RF during processing
might also influence process dynamics. Added fat could potentially
act as a lubricant within the system such that 'added-fat' systems
would have faster and 'fat-removed' systems would have slower
transit times, respectively. In addition, the process temperature
within different rendering systems was also poorly characterised.
F IGURE 2 Example of a simplified process flow diagram for the continuous/added-fat/vacuum rendering system
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Typically, only one temperature was quoted for each rendering sys-
tem. This was either the temperature of the rendered product
exiting the system, or the temperature recorded by the manufac-
turer's in situ temperature probes. However, these were not neces-
sarily in contact with the substrate.
Perhaps the greatest level of uncertainty regarding the ability of
rendering systems to inactivate TSE agents related to transit time.
Attempts to predict transit times mathematically from engineering
data such as fluid volumes and pump flow rates were only able to esti-
mate mean transit times, not the minimum considered important by
the SVC TSE Working Group. It was agreed that transit times could
potentially be measured using markers like those used to measure the
rate of passage of dietary components through the digestive tract of
animals (Uden et al., 1980). The technique involves mordanting (or
binding) an indigestible marker (e.g., Chromium) to the dietary compo-
nent in question (e.g., fibre). The mordanted component is then fed to
the animal and samples collected from a point within the digestive
tract, or in the faeces. The samples are then analysed for the marker
and plotted against time to give the minimum and mean rate of pas-
sage. However, in order to apply this technique to rendering systems,
a suitable marker and carrying component would need to be identi-
fied. The marker chosen would need to be inert, absent from ABP,
insoluble in water and easy to measure. Manganese dioxide (MnO2)
was considered to meet these criteria. In addition, the carrying com-
ponent would have to reflect the rate of passage of ABP through the
rendering system. As the solid fraction of raw ABP was essentially
bone-rich (>75%) and MBM was thought to be the most likely vector
for the BSE agent (Wilesmith et al., 1988), bone was considered to be
the most appropriate carrying component. However, bone proved dif-
ficult to separate from the ABP and mordant. Therefore, a substitute
to bone was developed which consisted of sand, cement and MnO2
as a marker. This was mixed and formed into balls (30 mm diameter)
prior to baking in an oven to produce briquettes which had the same
bulk density as bone and when passed through the anvil breakers pro-
duced material with the same particle distribution (Table 3). To date,
these briquettes are still used as part of the validation process for ren-
dering systems.
The briquettes were used to determine the transit time of ABP
through the different rendering systems. They were introduced into
each system when the process was operating under steady state con-
ditions. Three test runs were completed for each system, during which
the critical process parameters were monitored. The minimum transit
time was defined as the time at which the Mn concentration reached
three times the baseline followed by two consecutive increases. The
transit time studies confirmed that each system had a very different
transit time profile, with the 'continuous/added-fat/vacuum' system
having a minimum transit time of 10 min (Figure 3) and the 'continu-
ous/fat-removed/atmospheric' system having a minimum transit time
of 60 min. There was also considerable day-to-day variation within
three of the systems, although the SD around the minimum transit
time was relatively low. The identification of key process parameters
(Table 4), together with data from these transit time studies, enabled
the SVC TSE Working Group to formulate protocols for subsequent
pilot-scale TSE inactivation trials (BSE Inquiry, 2000).
3.4 | TSE inactivation trials
Two TSE inactivation trials were conducted to investigate the ability
of rendering systems to inactivate both the BSE and scrapie agents. In
order to do this, it was necessary to design and build pilot scale ren-
dering systems to replicate the key process parameters found in com-
mercial rendering plants (Woodgate, 1994) (Table 4). Full details of
both the BSE and scrapie inactivation trials are published by Taylor
et al. (1995, 1997), respectively. In summary, infected cattle or sheep
brains were collected, minced to 10 mm and blended with ABP in a
1:10 ratio prior to processing through the pilot scale rendering sys-
tems. Samples of the rendered product were then collected and
pressed to produce MBM and RF, which were then sent to the Insti-
tute of Animal Health Neuropathogenesis Unit (NPU), Edinburgh, for
bioassay of infectivity of the TSE agent using mice. Positive or nega-
tive results indicated whether TSE infectivity was confirmed or not
(Table 5). Infectivity titres (ID50) were also calculated following serial
dilution of the MBM used in the bioassay. The results of the BSE inac-
tivation trial confirmed that one system ('continuous/added-fat/vac-
uum') was ineffective in reducing the infectivity of the BSE agent
given the minimum retention time, whilst the other systems appeared
to be more effective. However, owing to partial removal of the cattle
brain tissue (approximately 10%) collected for histopathology, the ini-
tial infectivity of the MBM used in the BSE inactivation trial was lower
than expected and the results were treated with some caution. The
temperature and time profiles of the three continuous rendering sys-
tems that could potentially inactivate the BSE agent are presented in
Table 6. Importantly, these data were subsequently used to develop
validation methodology and draft EU legislation (Taylor &
Woodgate, 2003). The initial level of infectivity in MBM produced
from sheep brain material was significantly higher and therefore the
inactivation challenge greater. The scrapie trial subsequently con-
firmed that only the 'batch/as-received/hyperbaric' system was able
to inactive the TSE agent to below detectable levels.
TABLE 3 Characteristics of bone and the marker briquettes used
to quantify the transit time of animal by-products (ABP) through
rendering systems, after particle size reduction (mincing) through the
anvil breakers
Characteristic Bone Briquettes
Solubility (%) <1.0 <1.0
Bulk density (kg/l) 795 805
Particle size (%)
>30 mm 0 0
10–30 mm 37 41
2–10 mm 39 38
<2 mm 9 8
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4 | INITIAL LEGISLATIVE DEVELOPMENTS
The European Commission reacted to the BSE crisis by developing
new ABP processing regulations. A recognition that there were dif-
ferent levels of 'risk' associated with different types of ABP
resulted in the publication of Council Directive No. 90/667
(Council Directive, 1990). In this, low-risk and high-risk ABP were
defined, together with appropriate processing standards. However,
this was only considered to be a short-term regulation, to be
adapted or replaced depending on the results of the TSE inactiva-
tion trials. Subsequently, Commission Decision No. 92/562 intro-
duced the concept of critical control points (CCPs) into EU
rendering regulations (Commission Decision, 1992). Each rendering
system was described by a flow chart showing the key process
parameters (Table 4 and Figure 2). In effect these early legislative
developments proved to be staging points in the development of
more complex ABP regulations, many arising from the results of
the subsequent TSE inactivation trials. When the inability of the
'continuous/added-fat/vacuum' system to inactivate the BSE agent
was confirmed (Taylor et al., 1995), the system was immediately
banned (Commission Decision No. 94/382). Within this same regu-
lation all other continuous systems were approved subject to vali-
dation of key process parameters as determined in the TSE
inactivation trials (Table 6). However, when the scrapie inactivation
trial (Taylor et al., 1997) confirmed that none of the rendering sys-
tems were able to completely inactivate the scrapie agent a further
regulation was approved (Commission Decision No. 96/449), which
stipulated that all mammalian ABP must be processed at 3 bars
(absolute) pressure in excess of 133C for a minimum of 20 min
(Commission Decision, 1996).
F IGURE 3 Example transit time test for the 'continuous/added-fat/vacuum' rendering system (error bars indicate ±1.0 SD)
TABLE 4 Key process parameters for the six rendering systems operating in the European Union prior to the bovine spongiform









temperature (C) Anvil gap (mm)
Batch/as-received/atmospheric 150 150 120 120 150
Batch/as-received/hyperbaric 20 40 135 145 30
Continuous/added fat/vacuum 10 40 125 125 10
Continuous/as-received/atmospheric 50 125 125 140 30
Continuous/added fat/atmospheric 30 120 140 140 30
Continuous/fat removed/atmospheric 60 240 120 120 20
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With the introduction of Commission Decisions 92/562 and
94/382, the rendering industry was required to develop a process to
validate rendering systems under operational conditions (Commission
Decision, 1992, 1994). The approach adopted was to combine the
determination of minimum transit time with the temperature profile
of the system under steady state conditions. For each system, a vali-
dation test was conducted, with the results being used to produce a
validation graph (Figure 4). The x-axis represented both the length of
the system (0–1.0) and the minimum transit time (minutes) as deter-
mined using the method described previously. The y-axis represented
process temperature (C) measured using thermocouples introduced
at specific points in the system. The minimum times above key tem-
peratures (e.g., 100, 110, 120, 130C) were then calculated from the
graph. If the system met the process parameters as specified in
Table 6 it was approved, subject to specific operating conditions.
However, if under normal operation one of these operating conditions
was not met, the process was stopped, and the relevant condition
corrected before re-starting. Any rendered products produced during
this period were re-processed as raw ABP (SVC, 1994). The require-
ment for process validation and CCPs, first introduced in Commission
Decision 94/382 remain in force today in the form of Commission
Regulation No. 142/2011 (Commission Regulation (EU), 2011).
TABLE 5 Summary of the main
results from the transmissible spongiform
encephalopathy (TSE) inactivation trials
conducted by the Institute of Animal
Health, Neuropathogenesis Unit (NPU),
Edinburgh
Rendering system Minimum transit time (min)
Infectivity titre (ID50)
BSEa Scrapieb
Untreated TSE infected material 1.7 4.1
Batch/as-received/atmospheric 150 Negative 1.6
Batch/as-received/hyperbaric 20 Negative Negative
Continuous/added fat/vacuum 10 1.6 Positive
Continuous/as-received/atmospheric 50 Positive Positive
Continuous/added fat/atmospheric 30 Negative Positive
Continuous/fat removed/atmospheric 60 Negative Positive
Abbreviation: BSE, bovine spongiform encephalopathy.
aTaylor et al. (1995).
bTaylor et al. (1997).
TABLE 6 Temperature and time
profiles (minutes) of the continuous
rendering systems thought to inactivate
bovine spongiform encephalopathy (BSE)
following the inactivation trial (Taylor
et al., 1995)
Rendering system >80C >100C >110C >120C >130C
Continuous/as-received/atmospheric 95 55 13
Continuous/added fat/atmospheric 16 13 8 3
Continuous/fat removed/atmospheric 120 60
F IGURE 4 Representation of a
validation graph used to calculate the
minimum time animal by-products were
exposed to key temperatures during the
rendering process (100–110C = 17.5,
110–120C = 10.0 and 120–
130C = 7.0 min)
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5 | CURRENT LEGISLATION
On 20 March 1996 the Secretary of State for Health, Stephen Dorrell
pronounced, 'there was almost certainly a link between BSE in cattle
and new variant CJD in young adults' (BSE Inquiry, 2000). At the same
time, the Spongiform Encephalopathy Advisory Committee (SEAC)
minutes of 16 March 1996 noted that 'The Committee agreed to rec-
ommend that the use of mammalian MBM in feed for farm animals
should be prohibited'. Subsequently, the BSE Amendment Order
1996 (Order, 1996) was published bringing the UK feed ban into
effect. The assertion that BSE was linked to a human disease
resulted in recognition of the fact that the rendering industry was
intricately linked to the food supply chain and the imposition of fur-
ther regulatory controls on both the rendering industry and food
supply chain. Consequently, the European Commission agreed three
main themes underpinning subsequent ABP risk reduction legisla-
tion, that were, 'safe sourcing', 'safe processing' and 'safe use'
(Regulation [EC] 178/2002) (Regulation (EC), 2002a). This regulation
also laid down the legal basis for formation of the European Food
Safety Authority (EFSA) and confirmed that the rendering industry
was an important part of the 'food chain'. In practice, the regulations
that ensued focussed on the risk associated with different categories
of ABP, processing methods and the uses of rendered products
including disposal or use in animal feeds. Two other landmark regula-
tions were approved inter alia within a few months of each other,
Regulation (EC) No. 999/2001 and Regulation (EC) No. 1774/2002.
The former addressed the use of ABP in animal feeds and the latter
dealt with categorisation of ABP and associated processing stan-
dards. Both regulations were designed to complement each other
with the aim of controlling BSE in the first instance and then, by
future amendment of the regulations, allowing for a limited
reintroduction of animal proteins into animal feeds. Regulation
999/2001 confirmed the feed ban for animal proteins and intro-
duced the concept of specified risk material (SRM) which represen-
ted tissues from ruminant animals (cattle, sheep and goats)
considered to present the greatest risk of TSE transmission. These
were termed Category 1 ABP and were required to be removed from
animals slaughtered for human consumption and disposed of by
incineration. In practice, this meant rendering in a dedicated process
plant and disposal of the rendered products (MBM and RF) by com-
bustion in steam raising boilers or power generation plants. In prac-
tice, Category 1 and 2 ABP were processed together with the
resultant products being downgraded to Category 1. Regulation
1774/2002 defined different categories of ABP according to TSE
and other risks (Categories 1–3) and introduced a ban on the use of
open burning or on-farm burial as methods of ABP disposal except in
emergency situations. In addition, appropriate processing conditions
for each category of ABP and their potential uses were defined. In
essence, rendered products derived from Category 1 (mainly SRM)
and Category 2 (mainly deadstock) ABP were prohibited as ingredi-
ents in farm animal feeds. However, the use of PAP from Category
3 was approved subject to strict controls, such as no intraspecies
recycling. Many of the previous legislative requirements, including
those associated with system validation and hazard analysis and crit-
ical control point (HACCP) controls, were consolidated within Regu-
lation (EC) No. 1774/2002. However, this regulation has now been
superseded by Regulation (EC) No. 1069/2009 and its implementa-
tion text (Regulation (EC), 2009, Commission Regulation (EC) No.
142/2011), although the purpose and objectives of the new joint
regulations effectively remain the same as the 2002 regulation.
6 | MARKET ADJUSTMENTS
As a consequence of the BSE epidemic, the market for bovine (beef)
and rendered products collapsed, the former resulting from falling
consumer confidence and the latter resulting from a variety of restric-
tions placed on the use of rendered products. The EU ban on use of
animal-derived proteins in animal feeds (Regulation [EC] No.
999/2001) effectively eliminated the market for MBM and other ani-
mal proteins. As a result, MBM became a very undesirable commodity
and its value dropped from approximately £150 per tonne to close to
zero (A. C. Scott, 2017, personal communication). With no viable mar-
kets for rendered products the UK Government (and some EU coun-
tries) intervened with financial support to ensure that the rendering
industry could continue to operate and provide a service to the live-
stock and meat industries. However, following the loss of markets for
rendered products the rendering industry was forced to change its
business model and the costs associated with ABP processing were
passed down the chain with the ultimate recipients, farmers, receiving
lower prices for their livestock. At the same time, the rendering indus-
try sought to develop export markets for UK-derived MBM and dur-
ing the late 1990s and early 2000s significant quantities of MBM
were exported, mainly to the Far East (Narrod & Otte, 2001). How-
ever, this was soon curtailed by the Office Internationale des Epi-
zooties (OIE) who in 1997 began to develop global regulations
governing the international trade in animals and animal-derived prod-
ucts (OIE, 1999). In addition, many non-EU countries started to intro-
duce regulations governing rendering processes, both to harmonise
veterinary procedures and to prevent the 'dumping' of rendered prod-
ucts that were banned in their country of origin.
Although the BSE Amendment Order 1996 (Order, 1996) and
Regulation (EC) No. 999/2001 banned the use of animal-derived pro-
tein in animal feed it also provided the option for the ban to be lifted
if specific control conditions, such as prevention of intraspecies
recycling, could be satisfied in the future (Regulation (EC) No.
1744/2002). In 2005, a quantitative risk assessment confirmed that if
animal proteins were to be included in animal feeds in compliance
with EU regulations prohibiting the use of ruminant protein and ban-
ning the intraspecies recycling of nonruminant protein, the risk of a
new BSE epidemic was negligible (European Food Standards Agency
(EFSA), 2005). Effective implementation of the legislation required the
development of techniques for the identification of ruminant protein.
In 2012, a polymerase chain reaction (PCR) method for the determina-
tion of ruminant protein in complete feeds was validated (Fumière
et al., 2012) and subsequently approved by Commission Regulation
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(EC) No. 51/2013 (Commission Regulation (EC), 2013b). At the same
time, Commission Regulation (EC) No. 56/2013 authorising the use of
Category 3 nonruminant PAP in aqua feeds was also approved
(Commission Regulation (EC), 2013c). More recently, the 'relaxation'
of EU legislation governing ABP has continued with approval of Com-
mission Regulation (EC) No. 893/2017 authorising the export of Cate-
gory 3 ruminant PAP to non-EU countries under strictly controlled
conditions of confirmed provenance and secure transportation
(Commission Regulation (EC), 2017). The concept behind Commission
Regulation (EC) 893/2017 was to make ruminant PAP available to
non-EU countries where there might, 'in principle', be a demand for
ruminant animal proteins in pig and poultry diets. However, within the
EU it is unlikely that ruminant PAP will be authorised for use in pig
and poultry diets in the short to medium term because of limited seg-
regation between ruminant and nonruminant feed production by most
manufacturers.
7 | NEW MARKETS FOR RENDERED
PRODUCTS
In response to changes in the business environment the rendering
industry sought to 'add value' to both ABP and rendered products by
conducting research to support the development of new markets. The
fact that UK and EU legislation required that Category 1 (and by asso-
ciation Category 2) rendered products must be destroyed by incinera-
tion (Order, 1996) (EU Regulation (EC) No. 999/2001) meant that
rendered products could potentially be used as biofuels which could
be used to generate electricity and offset fossil fuel use in other sys-
tems. The main route for disposal of Category 1 MBM in the UK is
combustion in fluidised bed combustion power plants, with a resultant
reduction in the use of fossil fuels. Similarly, the use of Category 1 RF
as a fuel in Category 3 rendering plants could reduce the greenhouse
gas (GHG) emissions associated with Category 3 rendered products.
The GHG emissions of Category 1 RF are −0.77 kg CO2e kg−1. Conse-
quently, when used as a fuel in Category 3 rendering plants the GHG
emissions of Category 3 RF and PAP are 0.15 and 0.15 kg CO2
e kg−1,
respectively (Ramirez et al., 2012). The use of Category 3 rendered
products in other systems has the potential to significantly reduce
GHG emissions. For example, Category 3 RF has the potential to
replace other fat sources, such as palm oil in the oleo-chemical and
aqua-feed industries, which has GHG emissions of 2.1–2.6 kg CO2
e
kg−1 (Schmidt, 2010). Similarly, Category 3 PAP has the potential to
replace soya bean meal in animal diets, which has GHG emissions of
0.72 kg CO2
e/kg (Dalgaard et al., 2008).
Probably the most important research imperative concerning ren-
dered products related to their reintroduction into animal feeds. Fol-
lowing the EU insistence that no intraspecies recycling should be
allowed (Regulation (EC) No. 1774/2002), research focussed on
species-specific methods, including PCR for detecting PAP in animal
feeds. Two major EU research projects STRATFEED (Dardenne, 2005)
and SAFEED-PAP (Jorgensen & Baeten, 2013) confirmed that signifi-
cant DNA degradation occurred during the rendering process. The
challenge of using degraded DNA as the starting point for method
development meant that the reference materials also had to be pro-
duced under the same conditions (Woodgate et al., 2009). The devel-
opment and validation of a PCR method for the detection of ruminant
PAP in animal feeds (Fumière et al., 2012) has paved the way for
changes in legislation allowing the reintroduction of nonruminant PAP
into aqua feeds (Commission Regulation [EU] No. 56/2013). As a
result, the EU Feed Catalogue (Commission Regulation [EU] No.
2017/1017) now refers to PAP and includes the statutory declaration
required if such materials are incorporated into animal feeds
(Commission Regulation (EC), 2013a). An updated qualitative risk
assessment (European Food Standards Agency (EFSA), 2018) has
recently reconfirmed the negligible risk associated with use of animal
proteins in animal feeds if used in compliance with EU legislation,
including the use of porcine PAP in poultry diets and poultry PAP in
pig diets. In addition, it sets out the criteria required for a PCR test
such that a 'technical zero' can be reported for detection of species-
specific PAPs. Trials are currently underway to evaluate methods of
detecting both porcine and poultry PAP and the successful validation
of species-specific detection methods should pave the way for
reintroduction of porcine PAP into poultry feeds and poultry PAP into
porcine feeds. However, it is important to recognise that the nutri-
tional characteristics of modern PAPs are probably very different to
those of MBM prior to the BSE crisis or MBM produced in other parts
of the world.
As it was generally anticipated that changes in EU legislation
would initially permit the inclusion of nonruminant PAP into aqua-
feed research has tended to focus on the replacement of fishmeal and
vegetable protein sources in aqua feeds. Davies et al. (2009) reported
protein digestibility coefficients for nonruminant PAP of 0.85, 0.79
and 0.78 in European sea bass, Gilthead sea bream and Turbot,
respectively. In addition, Hatlen et al. (2015) reported that poultry
PAP could effectively replace 0.5 of the fishmeal in the diet of Atlantic
salmon without reducing performance. Similarly, Kumar et al. (2017)
reported that PAP and soya bean meal were equally effective in
replacing up the 0.6 of the fishmeal in Catfish diets and Davies
et al. (2019) reported that poultry PAP could effectively replace 0.75
of the fishmeal in juvenile gilthead sea bream diets. The inclusion of
PAP in aqua feeds may also confer positive benefits in terms of gut
health (Liland et al., 2015). To date, little research has been conducted
on the inclusion of nonruminant PAPs in the diets of other species,
although some work has been reported with laying hens (Van Krimpen
et al., 2010). However, with the potential reintroduction of non-
ruminant PAPs there is an urgent need for further research and feed
characterisation to ensure that they can be successfully incorporated
into pig and poultry diets, whilst also considering their potential
impact on both human and animal health and the environment.
8 | CONCLUSIONS
The BSE epidemic in 1986 highlighted the importance of the render-
ing industry as a key component in the food supply chain and
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emphasised the fact that economic imperatives, resulting in changes
in production methods can have unforeseen consequences in relation
to both animal and human health. Through the characterisation of
rendering processes and shaping of EU legislation the rendering indus-
try has played a crucial role in the elimination of BSE. Subsequent
research initiatives have continued to add value to rendered products
such that the rendering industry continues to operate and provide
both a valuable service and products to the livestock and meat indus-
tries. With the increasing demand for animal products and sustainable
intensification of production systems, the nutritional, environmental
and economic characteristics of PAPs mean that they represent valu-
able ingredients for inclusion in animal feeds. The EU has adopted a
more cautious approach than the rest of the world regarding the
utilisation of animal proteins in animal feeds, which limits the market
for and economic value of rendered products. Recent developments
in detection and quantification techniques have paved the way for
legislative changes allowing the safe reintroduction of nonruminant
PAPs into aqua feeds, and successful validation of species-specific
detection methods may soon facilitate their reintroduction into pig
and poultry feeds. However, resistance from key stakeholders (pro-
cessors, retailers and consumers) in the food chain remains a signifi-
cant challenge that must be overcome before their full potential can
be realised. Further research is required to characterise modern PAPs
and to ensure their appropriate, safe and acceptable inclusion in ani-
mal diets.
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